deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02153476

A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion

Sponsor: Allegro Ophthalmics, LLC

Conditions Symptomatic Focal Vitreomacular Adhesion
Interventions 2.0mg of ALG-1001 Balanced Salt Solution
Updated 11 times since 2017 Last updated: Nov 27, 2018 Started: Feb 28, 2014 Primary completion: Jun 30, 2015 Completion: Jun 30, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Symptomatic Focal Vitreomacular Adhesion, this trial is completed. The trial is conducted by Allegro Ophthalmics, LLC and has accumulated 11 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotCompleted~Aug 2018 – ~Dec 2018 · 4 months · monthly snapshotCompleted~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshotCompleted~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

11 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE2

▶ Show 6 earlier versions

  1. Jan 2019 — Jan 2021 [monthly]

    Completed PHASE2

  2. Dec 2018 — Jan 2019 [monthly]

    Completed PHASE2

  3. Aug 2018 — Dec 2018 [monthly]

    Completed PHASE2

  4. Jun 2018 — Aug 2018 [monthly]

    Completed PHASE2

  5. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE2

  6. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2

    First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Allegro Ophthalmics, LLC
Data source: Allegro Ophthalmics, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations